AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Bytey M 60mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Arrient Healthcare Pvt Ltd

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Bytey M 60mg/500mg Tablet SR

Diabex Duo 60mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision may elevate blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. To mitigate hypoglycemia risk, maintain regular mealtimes and carry a fast-acting glucose source. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Bytey M 60mg/500mg Tablet SR

Adult-onset diabetes

Major Benefits of Bytey M 60mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Administer Bytey M 60mg/500mg Sustained-Release Tablet with a meal.

Common Side effects of Bytey M 60mg/500mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Bytey M 60mg/500mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Bytey M 60mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume this extended-release tablet with a meal.

How Bytey M 60mg/500mg Tablet SR works:

Gliclazide and Metformin, a dual-action antidiabetic treatment, are combined in each extended-release Bytey M 60mg/500mg tablet.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Bytey M 60mg/500mg Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Bytey M 60mg/500mg SR tablets during pregnancy poses a confirmed risk to the fetus. Prescribing may occur exceptionally in life-threatening circumstances where benefits outweigh potential harm, as determined by a physician. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release combination of 60mg/500mg Bytey M tablets is likely not suitable for breastfeeding mothers. Preliminary research indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with kidney impairment should use Bytey M 60mg/500mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Bytey M 60mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Bytey M 60mg/500mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Bytey M 60mg/500mg Tablet SR :

Should you forget to take a Bytey M 60mg/500mg SR tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Bytey M 60mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Treatment Diabetes medication

FAQs on Bytey M 60mg/500mg Tablet SR

The sustained-release tablet, Bytey M 60mg/500mg, contains gliclazide and metformin. This dual-action medication manages type 2 diabetes mellitus in adults. Effective blood sugar control is achieved when combined with a healthy diet and physical activity. Gliclazide enhances pancreatic insulin secretion, thus reducing blood glucose. Metformin reduces hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for type 1 diabetes management.
Bytey M 60mg/500mg SR tablets are linked to several common adverse reactions. These include low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. While infrequent, serious side effects such as lactic acidosis may occur. Prolonged treatment may also result in vitamin B12 deficiency.
Indeed, Bytey M 60mg/500mg Sustained-Release Tablets can induce hypoglycemia. Manifestations of low blood sugar include nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is strongly recommended.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential adverse effect of Bytey M 60mg/500mg Tablet SR (also known as Metformin-associated lactic acidosis or MALA). This rare complication is preventable by avoiding use in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia warrant immediate discontinuation of Bytey M 60mg/500mg Tablet SR and prompt medical attention.
Prolonged administration of Bytey M 60mg/500mg Tablet SR can indeed lead to vitamin B12 insufficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Left unaddressed, this deficiency may result in anemia, neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, has been proposed by some investigators.
Patients with hypersensitivity to Bytey M 60mg/500mg Tablet SR components or excipients should not take this medication. Its use is contraindicated in individuals with moderate to severe renal impairment or metabolic acidosis, such as diabetic ketoacidosis.
Combining Bytey M 60mg/500mg SR tablets and alcohol is unsafe. This combination may dangerously reduce blood sugar (causing hypoglycemia) and raise the risk of lactic acidosis.
The sustained-release tablet, Bytey M 60mg/500mg, combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a balanced diet and regular physical activity. Gliclazide functions by stimulating insulin secretion from the pancreas, while metformin reduces hepatic glucose production and enhances insulin responsiveness. This formulation is unsuitable for managing type 1 diabetes.
Bytey M 60mg/500mg SR tablets may cause common adverse reactions such as low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects, including lactic acidosis, have also been reported. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, Bytey M 60mg/500mg SR tablets can induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar encompass nausea, headache, irritability, increased appetite, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. This adverse effect is more probable if meals are skipped or delayed, alcohol is consumed, excessive physical activity is undertaken, or concomitant antidiabetic medications are used. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential adverse effect of Bytey M 60mg/500mg Tablet SR (also known as metformin-associated lactic acidosis or MALA). This rare complication is preventable by avoiding use in individuals with impaired kidney function, the elderly, or those who consume significant quantities of alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should any of these symptoms occur, discontinue Bytey M 60mg/500mg Tablet SR immediately and seek urgent medical attention.
Prolonged ingestion of Bytey M 60mg/500mg Tablet SR can indeed lead to vitamin B12 insufficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Left unaddressed, this deficiency may result in anemia, neurological complications, including tingling and numbness in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, is recommended by some studies.
Patients with hypersensitivity to any ingredient or inactive substance in Bytey M 60mg/500mg Tablet SR should not use this medication. Similarly, its use is contraindicated in individuals with moderate to severe renal impairment or metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Bytey M 60mg/500mg Tablet SR is inadvisable. This combination risks further reduction of blood glucose, potentially causing hypoglycemia, and elevates the likelihood of lactic acidosis.
Bytey M 60mg/500mg Tablet...
81
MRP 99
18% off